- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AVIR
Recent news which mentions AVIR
Why Atea Pharmaceuticals Stock Is Sinking Today
November 17, 2021
From Motley Fool
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
November 17, 2021
From Benzinga
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
From Benzinga
From InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
November 17, 2021
From Benzinga
Atea Pharmaceuticals Inc (AVIR) Q3 2021 Earnings Call Transcript
November 12, 2021
Tickers
AVIR
From Motley Fool
Earnings Scheduled For November 11, 2021
November 11, 2021
From Benzinga
Should You Buy Pfizer Stock After the Fantastic COVID-19 Pill News?
November 09, 2021
From Motley Fool
Here's Why Merck Stock Vaulted Higher in October
November 08, 2021
From Motley Fool
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’
November 05, 2021
From MarketWatch
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
Is There Any Hope for Atea Pharmaceuticals Stock?
November 04, 2021
From Motley Fool
3 Beaten-Down Biotech Stocks -- Can They Recover?
October 31, 2021
From Motley Fool
How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market
October 29, 2021
From Motley Fool
Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral
October 28, 2021
From Benzinga
3 Top COVID Stocks -- Are They Tricks or Treats?
October 26, 2021
From Motley Fool
Was Atea Pharmaceutical's Flop Predictable?
October 26, 2021
From Motley Fool
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
October 25, 2021
From Benzinga
From Motley Fool
Why Atea Pharmaceuticals Stock Got Crushed This Week
October 22, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
October 20, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
October 20, 2021
From Benzinga
52 Biggest Movers From Yesterday
October 20, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher
October 19, 2021
From Benzinga
Why Ulta and Atea Rained on the Nasdaq's Parade Tuesday
October 19, 2021
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 19, 2021
From Benzinga
From Benzinga
Why Atea Pharmaceuticals Is Imploding Today
October 19, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.